Vogenx Inc (VOGX)
NASDAQ: VOGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
VOGX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $176.33M
- EPS (TTM)
- -$0.89
- Dividend yield
- None
- 52-week range
- 11.51 – 38.41
- Day range
- 11.87 – 13.30
- Volume / Avg
- 100.91K / 128.78K
- Beta
- —
- Shares outstanding
- 14.86M
52-week range
VOGX stock today
Shares of Vogenx (VOGX) finished lower on Nov 20 at $11.87, a drop of 7.30% or $0.935 per share, versus the S&P 500's 3.70% decline. At this level, VOGX sits near the bottom of its 52-week range of $11.51 to $38.41: 69.1% below the high, set on Sep 18, 2026 and 3.1% above the low. Vogenx has posted a net loss over the last twelve months (EPS of -$0.89), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Vogenx
Company profileVogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. James Green
- Headquarters
- Raleigh, NC
- Employees
- 4
- IPO year
- 2026
- Website
- vogenx.com
Analyst forecast
ForecastConsensus (1 analysts)
strong_buy
Avg. price target
$55.00+363.35%
- Strong buy 0
- Buy 1
- Hold 0
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 6, 2026
- EPS actual vs est.
- $-0.47 vs $-0.15
- Surprise
- -213.33%
VOGX news
All VOGX newsVogenx peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| NATRNature's Sunshine Products Inc. | 10.18 | +0.10% | $176.41M | vs VOGX |
| ADCTADC Therapeutics SA | 1.28 | -1.54% | $180.05M | vs VOGX |
| SIGASIGA Technologies Inc. | 2.40 | -9.43% | $172.45M | vs VOGX |
| SLGLSol-Gel Technologies Ltd. | 55.17 | +2.02% | $180.63M | vs VOGX |
| WHWKWhitehawk Therapeutics Inc. | 3.07 | -1.60% | $181.16M | vs VOGX |
| TRDAEntrada Therapeutics Inc. | 4.35 | -6.25% | $170.30M | vs VOGX |
| KRROKorro Bio Inc. | 12.18 | -0.08% | $167.18M | vs VOGX |
| RNACCartesian Therapeutics Inc. | 6.14 | +4.24% | $187.29M | vs VOGX |
Indexes, lists and sector
Vogenx stock FAQ
What is Vogenx's stock price today?
VOGX last traded at $11.87 as of Nov 20, 4:00 PM EST, down 7.30% on the day. Prices are delayed at least 15 minutes.
Who is Vogenx's CEO?
Mr. James Green is the chief executive officer of Vogenx Inc, which has about 4 employees.
What is the VOGX 52-week high?
The 52-week high for VOGX is $38.41 and the 52-week low is $11.51. The stock is currently 69.1% below its high.